Spyre Therapeutics, Inc. (SYRE) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Spyre Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -73.04x | -5.26x | -0.44x | -0.45x | -4.75x | -5.19x |
| P/B Ratio | 15.85x | 2.11x | 0.81x | 0.75x | 3.72x | 3.00x |
| P/S Ratio | 0.00x | 0.00x | 167.52x | 16.28x | 16.67x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 100.0% | 100.0% | 100.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | -27348.0% | -3640.2% | -350.3% | 0.0% |
| Net Margin | 0.0% | 0.0% | -38238.1% | -3598.8% | -351.1% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | -14401.8% | -3555.9% | -341.9% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 13.25x | 11.26x | 10.68x | 4.25x | 4.91x | 9.11x |
| Quick Ratio | 13.25x | 11.26x | 10.68x | 4.25x | 4.91x | 9.11x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.00x | 0.09x | 0.06x | 0.04x |
YoY = year-over-year change. Source: FMP..